HK1076816A1 - - Google Patents

Info

Publication number
HK1076816A1
HK1076816A1 HK05111431.9A HK05111431A HK1076816A1 HK 1076816 A1 HK1076816 A1 HK 1076816A1 HK 05111431 A HK05111431 A HK 05111431A HK 1076816 A1 HK1076816 A1 HK 1076816A1
Authority
HK
Hong Kong
Prior art keywords
chem
pharmaceutically acceptable
general formula
acceptable salt
active ingredient
Prior art date
Application number
HK05111431.9A
Other languages
English (en)
Inventor
Shiro Maeda
Toshiko Kita
Kanji Meguro
Original Assignee
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd filed Critical Hamari Chemicals Ltd
Publication of HK1076816A1 publication Critical patent/HK1076816A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK05111431.9A 2002-12-17 2005-12-12 HK1076816A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002365927 2002-12-17
JP2003363820 2003-10-23
PCT/JP2003/016131 WO2004054989A1 (ja) 2002-12-17 2003-12-16 新規２，４−ジアミノ−１，３，５−トリアジン誘導体

Publications (1)

Publication Number Publication Date
HK1076816A1 true HK1076816A1 (de) 2006-01-27

Family

ID=32599275

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05111431.9A HK1076816A1 (de) 2002-12-17 2005-12-12

Country Status (12)

Country Link
US (1) US7622469B2 (de)
EP (1) EP1574503B1 (de)
JP (1) JP4391422B2 (de)
KR (1) KR101027366B1 (de)
AU (1) AU2003289375A1 (de)
BR (1) BRPI0317188A8 (de)
CA (1) CA2510468C (de)
ES (1) ES2403141T3 (de)
HK (1) HK1076816A1 (de)
MX (1) MXPA05006450A (de)
NZ (1) NZ540972A (de)
WO (1) WO2004054989A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006018456D1 (de) * 2005-06-14 2011-01-05 Schering Corp Herstellung und verwendung von verbindungen als aspartylproteasehemmer
FR2896161B1 (fr) * 2006-01-13 2008-04-04 Merck Sante Soc Par Actions Si Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique.
DE102007054416A1 (de) * 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind
DE102008007314A1 (de) * 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
SI2300444T1 (sl) * 2008-05-23 2016-10-28 Poxel Sas Proces za sintezo derivatov 3,6-dihidro-1,3,5-triazina
WO2010024225A1 (ja) 2008-08-25 2010-03-04 浜理薬品工業株式会社 新規ジヒドロトリアジン誘導体
JP6487031B2 (ja) 2014-04-17 2019-03-20 イミューノメット セラピューティクス インコーポレイテッド グアニジン化合物、及びその用途
KR102216701B1 (ko) * 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
DE102018220624A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
DE102018220631A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
CN112642410A (zh) * 2020-12-01 2021-04-13 中国工程物理研究院核物理与化学研究所 一种用于水体中铀提取的抗菌聚合物纤维及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168519A (en) * 1961-10-17 1965-02-02 American Cyanamid Co 1-alkylphenyl-2, 2-di lower alkyl-4, 6-diimino-hexahydro-s-triazines
US3287366A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel 1, 2-dihydro-s-triazines
US3287365A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel dihydro-s-triazines and method of preparation
DE1620178A1 (de) * 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
JPS4541591B1 (de) 1967-12-11 1970-12-26
US5565451A (en) * 1994-09-15 1996-10-15 Fmc Corporation 1-substituted-2, 4-diamino-6, 6-dialkyl-1, 6-dihydro-1, 3, 5-triazines as insecticides
WO1999001442A1 (en) * 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
ES2249045T3 (es) 1998-12-01 2006-03-16 Bayer Cropscience K.K. 1,3,5-triazinas sustituidas como herbicidas.
FR2804113B1 (fr) 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
US7893096B2 (en) 2003-03-28 2011-02-22 Novartis Vaccines And Diagnostics, Inc. Use of small molecule compounds for immunopotentiation

Also Published As

Publication number Publication date
KR20050085720A (ko) 2005-08-29
BRPI0317188A8 (pt) 2018-05-08
ES2403141T8 (es) 2013-06-21
EP1574503A4 (de) 2008-06-25
WO2004054989A1 (ja) 2004-07-01
AU2003289375A1 (en) 2004-07-09
CA2510468C (en) 2011-01-04
ES2403141T3 (es) 2013-05-14
EP1574503B1 (de) 2013-03-13
CA2510468A1 (en) 2004-07-01
JPWO2004054989A1 (ja) 2006-04-20
US20060154928A1 (en) 2006-07-13
JP4391422B2 (ja) 2009-12-24
MXPA05006450A (es) 2005-08-19
BRPI0317188A2 (pt) 2005-11-01
KR101027366B1 (ko) 2011-04-11
NZ540972A (en) 2009-03-31
EP1574503A1 (de) 2005-09-14
US7622469B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
HK1076816A1 (de)
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
TW200728307A (en) Novel spirochromanone derivatives
RS24604A (en) Herbicides containing substituted thien- 3-yl-sulfonylamino (thio)carbonyl- triazolin(thi)one
WO2005046589A3 (en) Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
EP1704856A4 (de) Proteininhibitor der hsp90-familie
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
WO2002076918A8 (en) NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
EP1101755A4 (de) Anthranilsäurederivate
EP1026162A4 (de) Antirheumatika
HK1064673A1 (en) Fused-polycyclic compounds
EP1734046A4 (de) Radiosensibilisator
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
WO2005035528A3 (en) Triazole derivatives as antibacterial agents
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
WO2003086412A3 (fr) Derives poly-phosphonates pour compositions dentifrices
EP1557407A4 (de) Neue alpha-ketoamidderivate und deren verwendung
EP1757593A4 (de) Therapeutisches mittel gegen nichtvirale hepatitis
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
EP1464636A4 (de) Neue substanz mit antitumorwirkung/entzündungshemmender wirkung
EP1475382A4 (de) Verbindungen als semaphorininhibitoren

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20231215